Wu LL - Search Results

1

Regulatory T cells increase in breast cancer and in stage IV breast cancer.

Wang ZK, Yang B, Liu H, Hu Y, Yang JL, Wu LL, Zhou ZH, Jiao SC. Wang ZK, et al. Among authors: wu ll. Cancer Immunol Immunother. 2012 Jun;61(6):911-6. doi: 10.1007/s00262-011-1158-4. Epub 2011 Nov 25. Cancer Immunol Immunother. 2012. PMID: 22116346 Free PMC article.

2

Identification of an HLA-DPB1*0501 restricted Melan-A/MART-1 epitope recognized by CD4+ T lymphocytes: prevalence for immunotherapy in Asian populations.

Meng Z, Wang Y, Zhang G, Ke Y, Yan Y, Wu L, Huang Q, Zeng G, Wang Y, Ying H, Jiao S. Meng Z, et al. J Immunother. 2011 Sep;34(7):525-34. doi: 10.1097/CJI.0b013e318226bd45. J Immunother. 2011. PMID: 21760531 Free PMC article.

3

[Clinical significance of T lymphocyte subset changes after first line chemotherapy in peripheral blood from patients with advanced stage adenocarcinoma cell lung cancer].

Yan X, Zhao X, Jiao S, Sun S, Wu L, Wu Z. Yan X, et al. Zhongguo Fei Ai Za Zhi. 2012 Mar;15(3):164-71. doi: 10.3779/j.issn.1009-3419.2012.03.06. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22429580 Free PMC article. Chinese.

4

[Differential analysis of lymphocyte subsets between colorectal carcinoma patients and healthy individuals].

Zhang GQ, Jiao SC, Wen XY, Zhao H, Lin XS, Wu LL. Zhang GQ, et al. Among authors: wu ll. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Jul;28(7):735-7. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012. PMID: 22768866 Chinese.

5

Detection of T lymphocyte subsets in the peripheral blood of patients with advanced lung adenocarcinoma.

Yan X, Zhao X, Jiao SC, Hu Y, Sun SJ, Wu LL, Wu ZY. Yan X, et al. Among authors: wu ll, wu zy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Jun;34(3):234-8. doi: 10.3881/j.issn.1000-503X.2012.03.008. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012. PMID: 22776655

6

[Changes of lymphocyte subsets before and after chemotherapy in colorectal carcinoma patients].

Zhang GQ, Zhao H, Wen XY, Li JY, Wu LL, Jiao SC. Zhang GQ, et al. Among authors: wu ll. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Apr;35(2):155-60. doi: 10.3881/j.issn.1000-503X.2013.02.006. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013. PMID: 23643003 Chinese.

7

Adoptive immunotherapy for non-small cell lung cancer by NK and cytotoxic T lymphocytes mixed effector cells: retrospective clinical observation.

Zhang G, Zhao H, Wu J, Li J, Xiang Y, Wang G, Wu L, Jiao S. Zhang G, et al. Int Immunopharmacol. 2014 Aug;21(2):396-405. doi: 10.1016/j.intimp.2014.04.026. Epub 2014 May 29. Int Immunopharmacol. 2014. PMID: 24881900

8

Prolonged overall survival in gastric cancer patients after adoptive immunotherapy.

Zhang GQ, Zhao H, Wu JY, Li JY, Yan X, Wang G, Wu LL, Zhang XG, Shao Y, Wang Y, Jiao SC. Zhang GQ, et al. Among authors: wu ll, wu jy. World J Gastroenterol. 2015 Mar 7;21(9):2777-85. doi: 10.3748/wjg.v21.i9.2777. World J Gastroenterol. 2015. PMID: 25759549 Free PMC article.

9

Ascites-derived IL-6 and IL-10 synergistically expand CD14⁺HLA-DR^-/low myeloid-derived suppressor cells in ovarian cancer patients.

Wu L, Deng Z, Peng Y, Han L, Liu J, Wang L, Li B, Zhao J, Jiao S, Wei H. Wu L, et al. Oncotarget. 2017 Aug 10;8(44):76843-76856. doi: 10.18632/oncotarget.20164. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100353 Free PMC article.

10

New peptide MY1340 revert the inhibition effect of VEGF on dendritic cells differentiation and maturation via blocking VEGF-NRP-1 axis and inhibit tumor growth in vivo.

Mo Z, Yu F, Han S, Yang S, Wu L, Li P, Jiao S. Mo Z, et al. Int Immunopharmacol. 2018 Jul;60:132-140. doi: 10.1016/j.intimp.2018.04.025. Epub 2018 May 3. Int Immunopharmacol. 2018. PMID: 29730556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

922 results

Search Page

Filters